Zyxin Gene Expression in Patients with Varying Degrees of Coronary Artery Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157072 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Joanna Głogowska-Ligus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 40-055 Katowice, Poland. Hauptthemen laut MEDLINE: Coronary Artery Disease, Zyxin, Acute Coronary Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice.
Abstract (Originalsprache)
Acute coronary syndrome (ACS) remains the leading cause of mortality in developed countries. Although recent advances have improved our understanding of the pathophysiology of ACS and its primary consequence, myocardial infarction, many questions remain regarding the molecular and cellular changes occurring during and after an infarction. This study aimed to evaluate the expression levels of the zyxin (ZYX) gene in patients with ACS, stable coronary artery disease (stable CAD), and healthy controls. RNA was extracted from PBMCs and analyzed by quantitative real-time PCR (qRT-PCR). Gene expression was measured using TaqMan Gene Expression Assays and the number of ZYX mRNA molecules was quantified based on qRT-PCR kinetics. Kruskal–Wallis was used to compare gene expression levels among the three groups. A significantly higher number of ZYX gene copies was observed in both the ACS and stable CAD groups than in healthy controls (p < 0.0001 and p < 0.001, respectively). A statistically significant difference was also observed between the ACS and stable CAD groups (p = 0.004). The increased expression of zyxin observed in patients with ACS and stable CAD may reflect cellular repair mechanisms activated in response to myocardial injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department of Biostatistics, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
ORCID-Profile: Józefa Dąbek, Agata Wypych-Ślusarska, Klaudia Oleksiuk, Karolina Krupa-Kotara, Jerzy Słowiński
Förderung
- Medical University of Silesia in Katowice
Zitieren
APA
Głogowska-Ligus, J., Dąbek, J., Wypych-Ślusarska, A., Oleksiuk, K., Krupa-Kotara, K., Sobecko, E., Czech, E., & Słowiński, J. (2025). Zyxin Gene Expression in Patients with Varying Degrees of Coronary Artery Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157072
Vancouver
Głogowska-Ligus J, Dąbek J, Wypych-Ślusarska A, Oleksiuk K, Krupa-Kotara K, Sobecko E, et al. Zyxin Gene Expression in Patients with Varying Degrees of Coronary Artery Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157072
BibTeX
@article{GogowskaLigus2025,
author = {Głogowska-Ligus, Joanna and Dąbek, Józefa and Wypych-Ślusarska, Agata and Oleksiuk, Klaudia and Krupa-Kotara, Karolina and Sobecko, Ewelina and Czech, Elżbieta and Słowiński, Jerzy},
title = {Zyxin Gene Expression in Patients with Varying Degrees of Coronary Artery Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157072}
}
EUVIMED